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ABSTRACT 
Public Health Significance: HIV testing is an integral part of reducing new HIV infections in 
the United States, and needs to be increased among high-risk populations. A significant portion 
of transgender women (TGW) of color may not be aware of their HIV positive status, indicating 
a need to increase HIV testing. This is difficult because TGW of color are poorly represented in 
research and are often not targeted specifically by interventions.  
Methods: Data for this analysis came from Promoting Our Worth, Equality, and Resilience 
(POWER). In 2014 and 2015, POWER recruited Black men who have sex with men as well as 
TGW of color at Black Pride events in Philadelphia, PA; Houston, TX; Washington, D.C.; 
Detroit, MI; Memphis, TN; and Atlanta; GA. This analysis includes data from 304 transgender 
women. 
Results: Of TGW of color who did not self-report being HIV positive and had received a HIV 
test in their lifetime, 80.11% had received a HIV test in the previous six months, while 19.89% 
had not received a HIV test in the previous six months. Out of the entire sample, 30 individuals 
had never received a HIV test in their lifetime. Age was found to be negatively associated with 
receiving a HIV test in the previous six months (AOR=0.93; 95% CI 0.88, 0.99).  
Conclusion: Understanding the complex social and structural factors that influence decisions 
regarding HIV testing behaviors among TGW of color will be critical to developing effective 
interventions targeted for TGW of color. Overall, more research is needed to better understand 
the factors, barriers, and facilitators of HIV testing, and how the interactions between all three 
influence HIV testing decisions among TGW of color in the United States.  
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1.0  BACKGROUND 
Transgender women (TGW) experience some of the highest rates of HIV infection in the 
United States, but relatively little is known about the specific risk behaviors and lived 
experiences that contribute to the high prevalence and incidence rates. In 2011, the Williams 
Institute at the University of California, Los Angeles estimated the number of adult transgender 
males and females in the United States to be around 700,000, or 0.3% of the adult population in 
the United States [1]. In 2016, the Williams Institute published an updated report that analyzed 
data from the Centers for Disease Control and Prevention’s (CDC) Behavioral Risk Factor 
Surveillance System (BRFSS). The BRFSS collects data from adults in the United States, and 
while it does ask respondents about their gender identity, it is not targeted specifically for 
transgender individuals. The updated report estimated that the actual number of transgender 
adults in the United States could be as high as 1.4 million, or 0.6% of the total adult population 
of the United States [1]. As a specific population, transgender individuals are often neglected in 
terms of research and public health interventions [2]. Among the already underrepresented 
LGBT related research studies funded by the National Institutes of Health between 1989 and 
2011, only 6.8% focused on transgender populations [3]. The CDC does not uniformly collect 
data on transgender populations, and as a result transgender women are typically included in the 
same category as men who have sex with men (MSM) for research purposes [3,4]. This is 
problematic because TGW in the United States do not experience the same HIV infection risks 
as MSM, and can also face markedly different barriers to accessing healthcare services. While 
the need for more targeted HIV prevention services has been recognized by researchers, little 
evidence exists to inform the development of targeted services for TGW of color [5,6].      
HIV testing plays a significant role in preventing future cases of HIV and is a critical 
component in the effort to end the HIV epidemic in the United States. Earlier diagnosis of HIV 
leads to earlier initiative of treatment, which ultimately results in improved clinical outcomes [7]. 
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Early diagnosis of HIV is also instrumental in achieving viral suppression, which is critical for 
reducing the spread of sexually-transmitted HIV [7]. HIV positive individuals who are unaware 
of their HIV positive status account for almost one third of HIV transmission in the United 
States. In 2011, it was estimated that 14% of the 1.2 million individuals living with HIV in the 
United States were unaware of their HIV positive status [8]. The CDC currently recommends 
that sexually active MSM get tested on an annual basis if they do not have multiple/anonymous 
sexual partners, and every 3-6 months if they have multiple and/or anonymous sexual partners 
[8]. Because the CDC does not collect data on transgender individuals as a distinct 
epidemiologic population, TGW are included in the recommendations for MSM regarding HIV 
testing. This has the potential to be problematic because much less is known about the specific 
sexual behaviors and risk factors related to HIV for TGW compared to MSM. The CDC has also 
recommended that healthcare providers offer HIV testing on an opt-out basis, meaning that all 
individuals would be routinely tested unless they requested that the test not be run [9]. In 
addition, the lack of national surveillance of HIV incidence and prevalence rates among 
transgender individuals significantly limits the amount of evidence that can be used to advocate 
for increased funding of targeted interventions.   
In 2010, the National Center for Transgender Equality and the National Gay and Lesbian 
Task Force conducted a national survey among transgender individuals in the United States 
regarding discrimination, health, and access to healthcare. The National Transgender 
Discrimination Survey (NTDS) was answered by over 7,000 individuals, and found that 
transgender individuals, and particularly transgender women in the United States experience high 
rates of discrimination and substandard medical care due to gender identity/expression in their 
lifetimes [10]. The survey found that transgender individuals (male to female and female to 
male) in the United States experience HIV prevalence rates that are four times higher than the 
national average, at 2.64% compared to 0.6% for the general population [10]. Rates of 
discrimination in a medical setting and refusal of medical care were particularly high: 28% of 
respondents reported verbal harassment in a medical setting and 19% of respondents reported 
being denied medical care because of their gender identity/expression [10]. In particular, TGW 
experienced the highest amount of treatment denial in the entire sample, 22% of TGW in the 
survey reported being denied care based on their gender identity/expression [10]. Discrimination 
in a medical setting can have detrimental effects on healthcare access, and can have a strong 
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influence on individuals’ decisions about whether or not to access healthcare when needed. 
Postponement of accessing needed medical services due to discrimination by providers was 
reported by 22% of TGW in the survey, and postponement of accessing preventative services, 
such as HIV testing, was reported by 25% of TGW [10]. This is significant due to the high 
prevalence rates of HIV experienced by TGW, which are potentially being driven by high rates 
of previously unaware HIV positive individuals in the population.  
TGW of color experience poorer health outcomes than the general population, due to a 
variety of complex social and structural factors. A widely-cited meta-analysis estimated HIV 
prevalence among all transgender women in the United States to be 28%, although the lack of 
research focusing specifically on transgender health in the United States is a significant barrier in 
determining a more precise estimate [11]. The same meta-analysis found that African American 
transgender women experienced higher HIV prevalence rates: 56.3% based on test results, and 
30.8% based on self-reported data [11]. The intersection of racial and gender-identity for TGW 
of color can lead to health disparities due to the structural and social barriers that society has 
created and reinforced. In particular, it can contribute to disproportionately high rates of HIV 
which can then be exacerbated by limited access to competent healthcare among TGW of color 
in the United States. TGW also face a large number of unique structural barriers regarding 
employment, housing, and food security that contribute to increased risk for contracting HIV and 
poorer overall health outcomes [11,12]. In particular, experiences of employment-based 
discrimination have been found to be prevalent among TGW of color, and can often lead to 
detrimental health outcomes. Structural barriers for TGW have been associated with increased 
frequency of unprotected anal intercourse (UAI), increased victimization, and decreased 
readiness to change risky behavior [11,13,14].  
In addition, stigma and discrimination have been associated with increased risk for 
depression, suicide, and HIV in TGW [15]. Stigma and discrimination can lead to depression and 
low self-esteem among transgender women, which can influence substance use and rates of UAI 
[16]. Anticipated HIV stigma, or fear of discrimination based upon a positive diagnosis, has been 
shown to have negative effects on HIV testing frequency in MSM and TGW. One study found 
that anticipated HIV stigma was associated with a 60% decrease in the odds of HIV testing in the 
past 6 months, and that every standard deviation increase in anticipated stigma was associated 
with a 54% decrease in odds of having a HIV test in the past 6 months [17].  
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 There are several frameworks that can be used to better understand the complexity of 
social and structural factors that influence HIV testing behaviors among TGW of color. 
Syndemics is a term used to explain a set of mutually reinforcing interactions between a disease 
and various social factors. Due to the complexity of social and structural factors associated with 
HIV testing among TGW of color, using a syndemic framework to analyze the interactions could 
prove useful. Instead of social factors having a one-to-one relationship with a health outcome, 
there are reciprocal interactions that cumulatively result in the amplification of the disease and 
the factors that negatively affect health outcomes and/or increase risk for the disease [18,19]. 
Stall et al. first applied syndemics to HIV among MSM in the United States after recognizing 
that psychosocial issues among MSM seemed to be related [19]. Syndemics focuses on the 
additive effects that multiple factors can have on a health outcome, and has been successfully 
applied to both MSM and transgender women populations in the United States [19,20].  In 
addition to syndemics, Meyer’s Minority Stress Model is another useful framework that can 
potentially be applied to HIV testing among TGW of color. The model operates on the notion 
that chronic exposure to stress from stigma and discrimination can lead to psychological 
internalization and negative health outcomes [21]. The model was originally created to explain 
the effects of stigma and discrimination among sexual minorities, but has since been successfully 
applied to gender minority populations [20,21].  
The purpose of this analysis is to characterize HIV testing frequency, test site type, and 
reasons for postponing or not initiating HIV testing among TGW of color. In addition, this 
analysis will explore the association between discrimination in a medical setting and regularity 
of HIV testing as recommended by the CDC for high risk individuals. Specifically, we 
hypothesize that: 
Transgender women of color who have experienced medical-based discrimination within 
the previous year will be less likely to have received an HIV test in the last 6 months than 
transgender women of color who have not experienced medical-based discrimination within the 
previous year.  
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2.0  METHODS 
2.1 STUDY DESIGN AND POPULATION 
Data for this analysis came from the Promoting Our Worth, Equality, and Resilience 
(POWER) study. POWER used time-location sampling to recruit men who have sex with men 
(MSM) and transgender women (TGW) at Black Pride events in six cities across the United 
States during the summers of 2014, 2015, and 2016. This analysis was conducted using the data 
from 2014 and 2015 as data collection for 2016 was still ongoing at time of analysis. The study 
visited the following cities: Philadelphia, PA; Houston, TX; Washington, DC; Memphis, TN; 
Detroit, MI; and Atlanta; GA. Participants were sampled using time-location sampling, and 
survey weights were calculated. Recruited individuals were eligible to participate in the study if 
they: (1) were assigned male sex at birth, (2) self-reported having a male sexual partner in their 
lifetime, and (3) were 18 years or older. This analysis focused on transgender women of color 
and was restricted to individuals who: (1) identified as transgender, or reported having 
transitioned from male to female, and (2) self-identified as “Black” or “African American;” 
“Asian;” “Native Hawaiian/Pacific Islander;” and/or “Hispanic/Latino”. For gender identity, 
participants were asked to choose one of the following: (1) male; (2) female; or (3) transgender. 
This analysis included all participants who answered “transgender” to the following question. In 
addition, participants were asked “Do you identify as transgender OR have you transitioned from 
male to female or female to male gender?” Answers were dichotomous (yes/no), and individuals 
who answered “Yes” were eligible to be included in the analysis.  
Participants answered an anonymous self-administered, computer-assisted, behavioral 
health survey on electronic tablets. The survey was formulated to take approximately 20 minutes 
to complete, and participants were compensated with $10 upon completion. Participants were 
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assigned a unique identifier code, created by using a series of questions. Duplicate participants 
had only their first response included in the current analysis.  
Following completion of the survey, all participants were offered onsite, confidential 
HIV testing with a local community based organization (CBO). The CBOs utilized rapid HIV-
testing protocols of their choice, including OraQuick (OraSure Technologies, Inc., Bethlehem, 
PA), Clearview STAT-PAK (Alere Inc., Waltham, MA), and INSTI (bioLythical Laboratories, 
Richmond, BC) tests. Preliminary positive test results were confirmed using the existing 
confirmatory testing protocol of the given jurisdiction at an offsite location at a future date. 
POWER also offered anonymous HIV testing for individuals that declined confidential testing 
with the CBO. POWER staff utilized OraQuick for oral fluid, and did not report test results to 
participants. Participants who received a HIV test from either POWER or the CBO were 
compensated an additional $10.   
Unique subject ID numbers were used to link participant survey files to HIV test results. 
Participants that completed the survey, and a HIV test were compensated a total of $20. All study 
procedures were approved by the Institutional Review Board at the University of Pittsburgh.  
2.2 MEASURES 
Demographics 
Participants were asked to self-report age, highest education level, income before taxes, 
race, and ethnicity. For race, participants were initially asked if they identified as Black/African 
American. Participants that answered “yes” to the dichotomous question were considered to self-
identify as Black or African American for the purposes of this analysis. In addition, participants 
were also asked a separate question regarding identifying as Hispanic or Latino/a. This was a 
dichotomous question (yes/no), and participants that answered “Yes” were considered to self-
identify as Latino/a for the purposes of this analysis.  Participants were also asked to identify the 
ethnic group/groups that they considered themselves to be in, and were instructed to check all 
groups that applied. Participants were given the following choices: (1) Caucasian or White, (2) 
Asian, (3) Native Hawaiian or Pacific Islander, and (4) Other. Race and ethnicity were collapsed 
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into two dummy variables, one representing identifying as Black/not identifying as Black and the 
other representing identifying as Latino/not identifying as Latino. For highest education level, 
participants were asked to choose from the following choices: (1) Never attended school; (2) 
Grades 1 through 8; (3) Grades 9 through 12; (4) Grade 12 or GED; (5) Some college, 
Associate’s degree, or technical degree; (6) Bachelor’s degree; or (7) Any post graduate studies. 
For analysis, education level answers were recoded to create the following categories: (A) Never 
attended high school; (B) At least some high school; (C) Some college; (D) College diploma or 
more. Category A was created by combining choices 1 and 2, Category B by combining choices 
3 and 4, Category C was comprised solely of choice 5, and Category D was comprised of choices 
6 and 7. Participants were also asked to report their annual income before taxes in the past year. 
Participants were instructed to choose from the following categories: (1) <$9,999; (2) $10,000-
$29,999; (3) $30,000-$49,999; (4) $50,000-$69,999; (5) $70,000-$89,999; and (6) $90,000 and 
up.  
HIV Status 
HIV status was determined through the combination of self-report data from the survey 
and biological data. Individuals were considered to be HIV-positive if they: (1) had a preliminary 
HIV-positive test result, or (2) answered “HIV-positive” to “What was the result of you most 
recent HIV test?” Individuals were only considered to be HIV-negative if self-report data was 
confirmed via HIV test result. HIV status was coded as missing for individuals who either did 
not receive HIV testing or received an indeterminate test result from either POWER or the 
community partner, unless the individual had self-identified as HIV-positive.  
Knowledge of HIV-Positive Status 
Knowledge of HIV-positive status was determined using self-report and biological data. 
Individuals were considered to be previously diagnosed if they self-reported HIV-positive status 
in the survey. Individuals were considered to be previously unaware of their HIV-positive status 
if they received a HIV-positive test result and answered “HIV-negative,” “Indeterminate,” or “I 
don’t know,” when questioned about their most recent HIV test result. Using both HIV test 
results and survey answers, HIV-positive participants were classified as either: (1) previously 
unaware HIV-positives, or (2) previously aware HIV-positives.  
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HIV Testing: Lifetime and Within the Past Six Months  
Participants were asked if they had received a HIV test in the six months prior to the 
assessment date. Participants were also asked if they had ever been tested for HIV in their 
lifetime. Answers for both questions were dichotomous (Yes/No). Individuals who refused to 
answer were removed from the analytic sample.  
Location of Most Recent HIV Test 
Participants were asked to self-report the location of their most recent HIV test. 
Participants could choose from the following choices: (1) HIV counseling and test site, (2) 
HIV/AIDS street outreach program/mobile Unit, (3) drug treatment program, (4) needle 
exchange program, (5) correctional facility (jail or prison), (6) family planning or obstetrics 
clinic, (7) public health clinic/community health center, (8) private doctor’s office, (9) 
emergency room, (10) hospital, (11) at home, and (12) other location. Testing location was 
recoded to form the following categories which were used for the analysis: (A) counseling and 
testing site or mobile unit, (B) drug treatment or needle exchange facility, (C) jail or prison, (D) 
family planning or public health clinic, (E) doctor’s office or hospital, (F) at home, or (G) other 
location. Choices 1 and 2 were combined to make category A, 3 and 4 were combined to make 
category B, choice 5 became category C, choices 6 and 7 became category D, choices 8, 9, and 
10 became category E, choice 11 became category F, and choice 12 became category G. 
Frequency of each location category was calculated for all individuals in the analysis that had 
received a HIV test in their lifetime.   
Most Important Reason for Not Receiving a HIV Test: Lifetime and Past Six Months   
Participants who had never received a HIV test in their lifetime were asked to report the 
most important reason that described why they had not been tested for HIV. In addition, 
participants that had not received a HIV test in the six months prior to assessment date were 
asked to report the most important reason for not testing. For both questions participants could 
choose from the following choices: (1) you think you are at low risk for HIV infection, (2) you 
were afraid of finding out you had HIV, (3) you didn’t have time, (4) you were afraid of others 
finding out (confidentiality), (5) you were afraid others would judge you (stigma), (6) you didn’t 
trust the test to be accurate, (7) some other reason, and (8) no particular reason.  
Medical-Based Discrimination   
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Assessment of discrimination in a medical setting was based off of multiple survey 
questions. In Year 1 (2014) of the survey, participants answered a dichotomous question (yes/no) 
if they had experienced discrimination, been prevented from doing something, or been hassled or 
made to feel inferior due to race, being gay/having sex with men, HIV status, gender 
identity/expression, income or social class, or some other reason within the past year. 
Participants were also asked about the location of discrimination for each reason for 
discrimination, and were able to indicate multiple locations per reason. Individuals who 
answered “Yes” to the initial question and indicated “getting medical care” as a location of 
discrimination were considered to have experienced discrimination in a medical setting for the 
purposes of this analysis. In Year 2 (2015) of the survey, participants were first asked whether 
they had experienced discrimination, been prevented from doing something, or been hassled or 
made inferior in a particular location within the past year. Individuals who answered “Yes” to the 
initial question about location of discrimination were then asked about their self-perceived 
reasons for discrimination in the particular setting. Individuals were instructed to select all 
reasons that applied, and were able to choose from race, being gay/having sex with men, HIV 
status, income/socioeconomic status, and other reason(s). Individuals who answered “Yes” to the 
initial question regarding discrimination when trying to get medical care were considered to have 
experienced discrimination in a medical setting for the purposes of this analysis. Overall rates of 
medical-based discrimination in the previous year were analyzed by first concatenating variables 
representing reason for discrimination and a medical setting being the specific location of the 
discrimination for Year 1. This created five new variables which were grouped, excluding data 
points from Year 2, to form a new variable that represented all medical-based discrimination for 
Year 1. A variable representing the combined medical-based discrimination from both years was 
then generated by taking the row totals from both variables, producing a dichotomous variable 
that encompassed Year 1 and Year 2. For all discrimination variables, experiencing 
discrimination was coded as 1 and not experiencing discrimination was coded as 0.  
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2.3 ANALYSIS 
The analytic sample was restricted to individuals who either reported themselves to be 
HIV negative or were unaware of their HIV status. Descriptive statistics and demographic data 
were used to characterize the analytical sample of TGW of color. Frequencies in the following 
tables represent raw counts while percentages were calculated taking survey weights into 
consideration. Analysis was completed using version 14 of STATA (StataCorp, College Station, 
Texas) and all significance was set at alpha=0.05. Survey weights were incorporated as a 
separate variable, and were applied using the “svy” command prior to running analyses. The 
tabulation function was used to calculate both raw frequencies and weighted percentages for all 
demographic data, HIV status, knowledge of HIV status, HIV testing in the past six months or 
lifetime, HIV test location, and reasons for not receiving a HIV test.  
The frequency and weighted percentage of previously unaware HIV-positive infections 
were calculated for the sample.  Raw frequencies and weighted percentages were calculated for 
all demographic categories, HIV testing frequency, type of testing location, and reasons for not 
seeking HIV testing for individuals that had not received a HIV test in the previous six months or 
in their lifetime.  
 Bivariate analysis was used to compare the demographics of individuals who had tested 
in the previous six months to individuals who had not tested in the previous six months. 
Individuals who either reported that they were already aware of their HIV positive status or 
tested positive were removed from bivariate analysis. Race, ethnicity, medical-based 
discrimination, and highest education level were all compared across testers and non-testers 
using Pearson’s Chi Square test. Individuals with missing data were removed using listwise 
deletion per STATA default.  
A logistic regression model was used to test the effects of medical-based discrimination, 
age, annual income before taxes, and race/ethnicity on whether or not an individual had received 
a HIV test in the previous six months. Age was incorporated as a continuous variable. 
Individuals who reported that they were already aware of their HIV positive status were removed 
from the model. Study weights were incorporated into the model and city of assessment was 
controlled for. Individuals who had received a HIV test in the six months prior to the assessment 
date were compared to individuals who had not received a HIV test in the previous six months 
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but had at some point in their lifetime. In the logistic regression model, annual income was used 
to represent socioeconomic status (SES). Individuals who had never received a HIV test in their 
lifetime were excluded from the model due to the potential for significantly different structural 
factors that influence their decisions to not receive HIV testing than individuals who have a 
history of HIV testing but didn’t test recently. In particular, individuals who have never received 
a HIV test in their lifetime could have difficulties accessing medical care.  
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3.0  RESULTS 
 Table 1 shows the demographic characteristics of the 304 TGW of color in the sample. 
The mean age of the sample was 28.74, and while 23.37% had not attended high school, 26% 
had a college degree or higher, which illustrates the high level of diversity in the analytic sample. 
For race and ethnicity, 90.80% identified as Black, 9.08% identified as Caucasian or White, and 
18.26% identified as Latino, with individuals being able to identify with multiple 
races/ethnicities. For annual income before taxes, 33.30% made less than $9,999; 22.26% made 
between $10,000 and $29,999; 11.52% made between $30,000 and $49,999; 12.92% made 
between $50,000 and $69,999; 16.11% made between $70,000 and $89,999; and 3.90% made 
over $90,000.  
 Table 2 shows HIV testing behaviors and discrimination in a medical setting among 
TGW of color. Among TGW of color who had received a HIV test at some point in their 
lifetime, 19.89% had not received a HIV test in the previous six months. The majority of the 
sample had received a HIV test in the previous six months, indicating that most individuals were 
following the CDC guidelines for testing frequency. Out of the entire analytic sample of 304 
TGW of color, 30 had never received a HIV test in their lifetime.  
 Participants reported the most important reason for not receiving a HIV test for either the 
six months prior to the assessment date, or ever, depending on their HIV testing history. In both 
cases, low perceptions of risk for contracting HIV was a frequently reported reason participants 
delayed or avoided HIV testing, with 38.46% of individuals who had never received a HIV test 
and 22.71% of individuals who had not received a test in the previous six months reporting it as 
the most important reason. Stigma, or the fear of others judging them, was not reported as a 
reason for avoiding or delaying HIV testing, only 3.68% of individuals who had never been 
tested in their lifetime and 7.49% of individuals who had not tested in the previous six months 
reported it as the most important reason.  
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 Participants who had received a HIV test in their lifetime were asked to report the 
location of their most recent HIV test; 38.65% had tested at either a HIV counseling and testing 
site or mobile unit, 16.77% at a family planning or public health clinic, and 27.15% at a doctor’s 
office or hospital. Table 2 also shows the rate of discrimination in a medical setting as 
experienced by individuals in the sample. Out of the 202 individuals in the sample that identified 
as HIV negative or tested negative, 29.81% had experienced medical-based discrimination. HIV 
positivity, which was determined by correlating survey responses and HIV tests, was 37.89% 
(n=102) for the sample, and 53.11% (n=49) of individuals that tested positive for HIV were 
previously unaware of their HIV status. 
 Table 3 shows the results of the bivariate analysis that was used to compare 
characteristics of TGW of color that had received a HIV test in the previous six months to TGW 
of color that had not received a HIV test in the previous six months. Race, ethnicity, education 
level and medical-based discrimination did not differ significantly between the two groups.  
 Table 4 shows the results of the logistic regression model. The model ultimately did not 
find medical-based discrimination, annual income, ethnicity, or race to be significantly 
associated with odds of receiving a HIV test in the previous six months. However, age was found 
to be negatively associated with HIV testing within the previous six months with an adjusted 
odds ratio of 0.92 (95% CI 0.88-0.98). TGW of color were less likely to have received a HIV test 
within the previous six months as their age increased.   
 
Table 3-1. Characteristics of transgender women of color: United States, 2014-2015 
    n=304 
    n (%) 
Demographics      
Education (n=301)     
    Never attended high school    63 (23.37)    
    At least some high school    110 (30.17)   
    Some college    65 (20.47) 
    College diploma or more     63 (26.00)   
City of data collection* (n=304) 
    Philadelphia, PA    40 (13.16)  
    Houston, TX    68 (22.37)  
    Washington, D.C.    59 (19.41)  
    Detroit, MI    68 (22.37)  
    Atlanta, GA    61 (20.07)  
    Memphis, TN    8 (2.63)   
Age mean (SD)    28.74 (9.49) 
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Table 3-1 Continued 
Race (n=304)  
    Black     283 (90.80)  
    Not Black    21 (9.20) 
Ethnicity (n=304) 
    Latino    38 (18.26) 
    Not Latino     266 (81.74) 
Annual income 
    <$9,999    125 (33.30) 
    $10,000-$29,999    65 (22.26) 
    $30,000-$49,999    32 (11.52) 
    $50,000-$69,999    28 (12.92) 
    $70,000-$89,999    35 (16.11) 
    $90,000 and up    11 (3.90) 
Note: Numbers are unweighted counts, percentages reflect weighted proportions  
*City of data collection is unweighted 
 
Table 3-2. HIV testing and discrimination among transgender women of color: 
United States, 2014-2015 
        n (%) 
Location of most recent HIV test (n=201)  
    Counseling and testing or mobile unit    102 (38.65) 
    Drug treatment and needle exchange facilities    6 (2.10) 
    Jail or prison    15 (6.22) 
    Family planning/OB/public health clinic    44 (16.77) 
    Doctor’s office or hospital    81 (27.15) 
    At home    7 (3.79) 
    Other    13 (5.33)  
Testing frequency (n=218)  
    Tested in the past 6 months    178 (80.11) 
    Not tested in the past 6 months    40 (19.89) 
Most important reason for not getting a HIV test (lifetime; n=30)  
    Low perceived risk for HIV infection    8 (38.46)    
    Afraid of finding out you had HIV    3 (18.32) 
    Didn’t have time    3 (20.49)    
    Afraid of others judging you (stigma)    1 (5.68)    
    Didn’t trust the test to be accurate    1 (2.24) 
    Other reason    2 (10.91) 
    No particular reason     2 (3.91) 
Most important reason for not getting a HIV test (past 6 months; n=39)  
    Low perceived risk for HIV infection     7 (21.19) 
    Afraid of finding out you had HIV     3 (3.42) 
    Didn’t have time     10 (21.28) 
    Afraid of others judging you (stigma)    3 (9.02) 
    Didn’t trust the test to be accurate     1 (8.00) 
    Other reason     9 (25.84) 
    No particular reason     6 (11.25)  
HIV positivity (n=304) [95% CI]    102 (37.89) [32.44, 43.34]  
    Previously unaware HIV positive    49 (53.11)  
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Table 3-2 Continued  
Medical-based discrimination (n=251)     
    Experienced    62 (27.80) 
    Did not experience     189 (72.20)  
Note: Numbers are unweighted counts, percentages reflect weighted proportions 
 
Table 3-3. Comparison of transgender women of color who have received a HIV test in the 
previous six months to transgender women of color who have not received a HIV test in the 
previous six months: United States, 2014-2015 
 
                                                               Tested in     Didn’t test in 
                                                               past 6 mo.                          in past 6 mo.           
                                                     n=178                              n=40      p      
                   
Demographics 
Education                                                                                                               0.500   
    Never attended high school          43        7 
    At least some high school            61        13 
    Some college                                42        8 
    College diploma or more             32        11 
Annual income             0.826 
    Under $9,999                               74    14  
    $10,000-$29,999                          42    6  
    $30,000-$49,999                          22    5 
    $50,000-$69,999                          16    4 
    $70,000-$89,999                          16    3 
    $90,000 and up                             7    3 
Identify as Black                             165    38         0.603 
Do not identify as Black                  13                             2  
Identify as Latino                             26     4                 0.445 
Do not identify as Latino                152    36 
Medical-Based Discrimination (n=218)             0.182 
Experienced                                      40    13                      
Did not experience                           138    27 
 
 
Table 3-4. Logistic regression of predictors for receiving a HIV test in the previous six 
months among transgender women of color: United States 2014-2015 
 
(n=212)                                               OR                     95% CI                      p 
    
Age                                                     0.93            0.88, 0.99  0.020* 
Annual Income                                   0.75                0.53, 1.06  0.101    
Identifying as Latino                          1.37             0.22, 8.59  0.737 
Identifying as Black                           0.98             0.08, 11.43                  0.986 
Medical-based discrimination            0.32            0.08, 1.35  0.121    
*denotes p<0.05  
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4.0  DISCUSSION 
4.1 DISCUSSION AND RECOMMENDATIONS 
This analysis compared TGW of color who had received a HIV test in the past six months 
to TGW of color who had not received a HIV test in the past six months. Individuals in these 
groups did not differ significantly in terms of race, ethnicity, experiencing medical-based 
discrimination, or education level. Age was found to be negatively associated with receiving a 
HIV test in the previous six months, with odds of receiving a test within the previous six months 
decreasing with increasing age. Because many TGW of color believed themselves to be at low 
risk for HIV, HIV awareness and testing campaigns should be tailored specifically to TGW of 
color. Target age of TGW of color needs to be considered during the development of future 
interventions, and future research is needed to determine if risk factors change with age in TGW 
of color. Location of HIV testing also needs to be considered when planning future public health 
interventions targeting HIV testing and TGW of color. TGW of color do utilize traditional 
healthcare venues such as doctors’ offices and clinics for HIV testing, but 38.65% of HIV 
negative individuals in the sample listed either a counseling and testing center or mobile HIV 
testing unit as the location of their most recent HIV test. While educating providers on how to 
provide competent care for transgender individuals should be a priority, future HIV testing 
interventions for TGW of color should also utilize non-traditional testing venues.  
This study demonstrates the discordance between the high prevalence rate of HIV and 
relatively high uptake of consistent testing among TGW of color in the United States. HIV 
positivity was almost 38% for our sample, which exceeds the estimate of 28% for all TGW in the 
United States and indicates that TGW of color are at an increased risk for contracting HIV. More 
importantly, over half of the TGW of color in this sample that tested positive for HIV were 
previously unaware of their HIV positive status. Late diagnosis of HIV can have disastrous 
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consequences for both the individual and their sexual partners. Individuals that are unaware of 
their HIV positive status are unable to enter the care continuum and are more likely to transmit 
HIV to other individuals. In addition, individuals who are diagnosed during later stages of the 
disease progression are at a higher risk for mortality and are less likely to respond to 
antiretroviral treatment [7].  
TGW of color are disproportionately burdened with both HIV and unknown HIV 
positivity. The Medical Monitoring Project estimates that 18.1% of individuals living with HIV 
in the United States are unaware of their HIV positive status, which is in stark contrast to the 
53% of the HIV positive individuals in this analysis who were previously unaware of their HIV 
positive status [22]. While there are many structural barriers that affect TGW of colors’ ability to 
access healthcare services, stigma and discrimination from healthcare providers or other patients 
could play a role in decisions regarding HIV testing, namely how frequently individuals decide 
to get tested. In addition, this analysis found that many TGW of color delayed or avoided HIV 
testing because they believed that they were at low risk for infection. Of TGW of color that had 
not received a HIV test ever, almost 40% did not get tested because they believed themselves to 
be at low risk for HIV. Of individuals that had not received a HIV test in the previous six 
months, only 22.71% reported low perception of risk as the most important reason for delaying 
testing. Lack of time and fear of others finding out about their HIV status were also major 
reasons individuals avoided HIV testing. Self-perception of risk is a powerful driver of decisions 
regarding HIV testing, and while a relatively small portion of this sample had not received a HIV 
test in their lifetime it is important to consider the ramifications in the broader scope of the HIV 
epidemic in this country.  
Stigma and discrimination have the potential to play large roles in the decisions that 
TGW make regarding accessing both preventative and necessary healthcare services in the 
United States. Transgender adults frequently experience barriers to accessing competent 
healthcare services in the United States. The NTDS found that transgender adults in the United 
States were more likely to experience medical-based discrimination if their provider was aware 
of their transgender status [10]. While the TGW of color that participated in this study may have 
experiences that differ from the general population of transgender adults or even the general 
population of TGW of color in the United States, this analysis highlights the need for a more 
thorough examination of the structural and social barriers associated with HIV testing decisions 
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among TGW of color. Few studies have focused on the specific role that experiences of 
discrimination play with regards to HIV testing behaviors among TGW of color in the United 
States. The NTDS found that 25% of TGW had postponed receiving preventative medical care 
due to discrimination by providers, although the survey only asked about refusal of care and 
verbal/physical harassment in terms of discrimination [10]. It is important to consider 
discrimination in a broader scope, as the cumulative effect of microaggressions over time can 
also have a dramatic effect on the health outcomes of TGW of color. Operario et al discussed the 
importance of microaggressions and cumulative discrimination as they relate to syndemics and 
health outcomes for TGW [20]. The study also found that the association between stigma and 
health outcomes in TGW followed the predictions of Meyer’s Minority Stress Model. Meyer’s 
model focuses on sexual minority populations, although the constructs can be applied to other 
minority populations that experience high levels of stress due to stigma and discrimination [21]. 
While Meyer conceptualized his model based off of sexual minority populations like MSM, 
Operario et al also found that Meyer’s model could be successfully applied to TGW, indicating 
that the principles of the model hold true for gender minorities as well as sexual minorities 
[20,21].  
Both syndemics and Meyer’s Minority Stress Model should be considered as theoretical 
frameworks for future studies looking at HIV testing among TGW of color. Stall et al first 
applied syndemics to HIV among MSM in the United States, and found that the interaction of 
psychosocial factors interacted with HIV risk behaviors to put individuals at increased risk for 
HIV infection. Operario et al examined interactions between unprotected anal intercourse, 
alcohol intoxication and illicit drug use among TGW in the United States, and found evidence of 
a syndemic among HIV-related behaviors [20]. It is possible that rather than a straightforward 
one-to-one relationship between structural and social factors effecting HIV testing decisions 
among TGW of color, there is an interplay that causes negative amplification on both sides. 
Essentially, TGW of color who face significant structural barriers that increase their risk for HIV 
are also prevented from accessing HIV testing due to those same barriers, although more 
research is needed to better understand if a syndemic is present.   
Despite high rates of consistent HIV testing among TGW of color, over half of the 
individuals that tested positive for HIV were previously unaware of their status. Access to 
healthcare and health insurance were not examined in this analysis, and it is possible that the 
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ability to access healthcare services may play a role in shaping decisions around HIV testing for 
TGW of color in the United States. Among all transgender adults surveyed by the NTDS, overall 
19% lacked health insurance and 31% of Black/African American respondents were uninsured 
[10].  While the number of individuals that were unaware of their status was small relative to the 
entire sample, the effect that those individuals have on community transmission rates and viral 
load has the potential to be significant. Furthermore, it would be worthwhile to examine the 
sexual networks and sexual behaviors of these individuals. In general, more in-depth qualitative 
research focusing specifically on previously undiagnosed HIV positives and their decisions 
regarding HIV testing would shed light on this disconnect between testing frequency and the 
high rate of previously undiagnosed HIV positive TGW of color.  
4.2 LIMITATIONS 
 It is important to note that there are several limitations with this study that must be 
considered. Data regarding testing frequency, location type, and reason for delaying or avoiding 
testing were all self-reported, and individuals were limited to a number of choices. There are 
many factors that influence individuals’ decisions about where and when to get tested, and why. 
Participants were only able to select the most important reason for delaying or avoiding HIV 
testing, while in reality the decision could be influenced by multiple reasons. Individual 
decisions regarding HIV testing are often complex, and the quantitative nature of this study may 
limit our ability to fully understand the interactions between participants’ beliefs about their own 
risk, stigma, and other structural factors that shape their decisions.  
 The findings of this study are not necessarily generalizable to all TGW of color in the 
United States. TGW of color who attend Black Pride events may differ significantly from TGW 
of color who do not attend these events. Attending Black Pride events can require significant 
investments of time and money from the participants, so it is possible that factors like income, 
employment, and ability to travel influence attendance of Black Pride events. Transgender adults 
in the United States experience high rates of housing and employment instability. It is also 
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important to note that the majority of the participants of the POWER study are BMSM, and that 
the questions in the survey are more applicable to the experiences of BMSM than TGW of color.  
 There are also limitations with the analysis of medical-discrimination rates and its effect 
on HIV testing frequency. It is possible that individuals who have tested in the previous six 
months experienced more medical-based discrimination simply because they were accessing 
healthcare services more frequently than individuals who had not tested in the previous six 
months. TGW of color that access healthcare more frequently might experience an increase in 
their chances of experiencing medical-based discrimination because they have more chances for 
medical-based discrimination to occur. It is also important to note that medical-based 
discrimination was not categorized by reason for discrimination for the purposes of this analysis. 
The survey did ask participants to report the reasons for discrimination, although for this analysis 
reason for discrimination was determined to be inconsequential as the overall effect of medical-
based discrimination was of interest. The purpose of this study was to look at the overall effect 
that discrimination has on HIV testing frequency, and location of discrimination was determined 
to be more representative of TGW of colors’ experiences as they related to HIV testing 
frequency. The survey only asked about experiences of discrimination within the previous year, 
which might not fully illustrate TGW of colors’ experiences of discrimination. Other studies 
have also highlighted the potential for discrimination to have a cumulative effect, which would 
make it a difficult measure to capture in a cross-sectional study. The study also refers to 
discrimination as discrete events, while in reality more nuanced forms of discrimination such as 
microaggressions could have the potential to have the same effects as larger, singular events, 
particularly if taken cumulatively.   
For the logistic regression model, TGW of color who had never received a HIV test in 
their lifetime were excluded from the model. While this does decrease the size of the analytic 
sample, non-testers made up approximately 10% of the entire sample of 304 TGW of color. 
While this is an important group to look in regards to discrimination and decisions regarding 
HIV testing, the lived experiences of non-testers have the potential to differ significantly from 
TGW of color who have been tested in their lifetimes, and it is likely that the model used would 
not be applicable. Annual income before taxes was used instead of education level in the logistic 
regression model because of the unique employment bias that TGW of color experience in this 
country. Transgender individuals in the United States experience high rates of employment 
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discrimination, and thus education level has the potential to inaccurately characterize 
socioeconomic status. In 2011, a survey of transgender individuals found that 78% had 
experienced at least one form of harassment or mistreatment in the workplace [23]. In addition, 
the unemployment rate for transgender individuals of color in the United States is over four 
times the national unemployment rate [23].  For this analytic sample over half of the participants 
made less than $30,000 annually before taxes, but 26% had a Bachelor’s degree or higher. This 
discrepancy along highlights the potential problems with using highest education level, as it does 
not accurately reflect the true SES of the sample.  
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5.0  CONCLUSION 
While the majority of TGW of color in this analysis had been tested for HIV within the 
previous six months, the high prevalence rate of HIV combined with the large proportion of HIV 
positives that were previously unaware of their status is troubling. It is very clear that 
interventions targeting HIV testing and status awareness among TGW of color are needed within 
the United States. Currently, the development of such interventions is hindered by how little is 
known about TGW of color due to the lack of representation in research in this country [3]. More 
research exploring the interactions between discrimination, stigma, socioeconomic status, and 
HIV testing decisions in TGW of color is ultimately needed, as it is likely that TGW of color 
face unique structural and social barriers resulting in equally unique lived experiences. In 
particular, both quantitative and qualitative methods need to be utilized in order to fully 
understand the influence that stigma and discrimination have on HIV-related health disparities 
among TGW of color.  
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